Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study: a multicenter cohort observational study
- PMID: 30309342
- PMCID: PMC6180570
- DOI: 10.1186/s12882-018-1030-2
Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study: a multicenter cohort observational study
Abstract
Background: Decline of renal function is common in older persons and the prevalence of chronic kidney disease (CKD) is rising with ageing. CKD affects different outcomes relevant to older persons, additionally to morbidity and mortality which makes CKD a relevant health burden in this population. Still, accurate laboratory measurement of kidney function is under debate, since current creatinine-based equations have a certain degree of inaccuracy when used in the older population. The aims of the study are as follows: to assess kidney function in a cohort of 75+ older persons using existing methodologies for CKD screening; to investigate existing and innovative biomarkers of CKD in this cohort, and to align laboratory and biomarker results with medical and functional data obtained from this cohort. The study was registered at ClinicalTrials.gov, identifier NCT02691546, February 25th 2016.
Methods/design: An observational, multinational, multicenter, prospective cohort study in community dwelling persons aged 75 years and over, visiting the outpatient clinics of participating institutions. The study will enroll 2450 participants and is carried out in Austria, Germany, Israel, Italy, the Netherlands, Poland and Spain. Participants will undergo clinical and laboratory evaluations at baseline and after 12 and 24 months- follow-up. Clinical evaluation also includes a comprehensive geriatric assessment (CGA). Local laboratory will be used for 'basic' parameters (including serum creatinine and albumin-to-creatinine ratio), whereas biomarker assessment will be conducted centrally. An intermediate telephone follow-up will be carried out at 6 and 18 months.
Discussion: Combining the use of CGA and the investigation of novel and existing independent biomarkers within the SCOPE study will help to provide evidence in the development of European guidelines and recommendations in the screening and management of CKD in older people.
Trial registration: This study was registered prospectively on the 25th February 2016 at clinicaltrials.gov ( NCT02691546 ).
Keywords: Ageing; Chronic kidney disease; Disability; Frailty; Older people.
Conflict of interest statement
Ethics approval and consent to participate
Ethics approvals have been obtained by Ethics Committees in participating institutions as follows:
Italian National Research Center on Aging (INRCA), Italy, #2015 0522 IN, January 27, 2016.
University of Lodz, Poland, #RNN/314/15/KE, November 17, 2015.
Medizinische Universität Graz, Austria, #28–314 ex 15/16, August 5, 2016
Erasmus Medical Center Rotterdam, The Netherland, #MEC-2016-036 - #NL56039.078.15, v.4, March 7, 2016.
Hospital Clínico San Carlos, Madrid, Spain, # 15/532-E_BC, September 16, 2016
Bellvitge University Hospital Barcellona, Spain, #PR204/15, January 29, 2016.
Friedrich-Alexander University Erlangen-Nürnberg, Germany, #340_15B, January 21, 2016.
Helsinki committee in Maccabi Healthcare services, Bait Ba-lev, Bat Yam, Israel, #45/2016, July 24, 2016.
All patients must give their written informed consent before entering the study.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
-
- Farrington Ken, Covic Adrian, Aucella Fillipo, Clyne Naomi, de Vos Leen, Findlay Andrew, Fouque Denis, Grodzicki Tomasz, Iyasere Osasuyi, Jager Kitty J., Joosten Hanneke, Macias Juan Florencio, Mooney Andrew, Nitsch Dorothea, Stryckers Marijke, Taal Maarten, Tattersall James, Van Asselt Dieneke, Van den Noortgate Nele, Nistor Ionut, Van Biesen Wim. Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2) Nephrology Dialysis Transplantation. 2016;31(suppl 2):ii1–ii66. doi: 10.1093/ndt/gfw356. - DOI - PubMed
